These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

880 related articles for article (PubMed ID: 19055698)

  • 41. [Safety, stability and immunogenicity of an oral DNA vaccine against Newcastle disease].
    Liang XY; Fang WH; Jiang LL
    Sheng Wu Gong Cheng Xue Bao; 2003 Jan; 19(1):24-9. PubMed ID: 15969031
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mucosal and systemic immunization elicited by Newcastle disease virus (NDV) transgenic plants as antigens.
    Berinstein A; Vazquez-Rovere C; Asurmendi S; Gómez E; Zanetti F; Zabal O; Tozzini A; Conte Grand D; Taboga O; Calamante G; Barrios H; Hopp E; Carrillo E
    Vaccine; 2005 Dec; 23(48-49):5583-9. PubMed ID: 16099555
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of Chicken Interferon Gamma on Newcastle Disease Virus Vaccine Immunogenicity.
    Cardenas-Garcia S; Dunwoody RP; Marcano V; Diel DG; Williams RJ; Gogal RM; Brown CC; Miller PJ; Afonso CL
    PLoS One; 2016; 11(7):e0159153. PubMed ID: 27409587
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mouse strain-dependent differences in enhancement of immune responses by C3d.
    Toapanta FR; Ross TM
    Vaccine; 2004 Apr; 22(13-14):1773-81. PubMed ID: 15068861
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vaccination with Newcastle disease vaccine and CpG oligodeoxynucleotides induces specific immunity and protection against Newcastle disease virus in SPF chicken.
    Linghua Z; Xingshan T; Fengzhen Z
    Vet Immunol Immunopathol; 2007 Feb; 115(3-4):216-22. PubMed ID: 17157392
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of the fusion glycoprotein of Newcastle disease virus in transgenic rice and its immunogenicity in mice.
    Yang ZQ; Liu QQ; Pan ZM; Yu HX; Jiao XA
    Vaccine; 2007 Jan; 25(4):591-8. PubMed ID: 17049688
    [TBL] [Abstract][Full Text] [Related]  

  • 47. DNA vaccination with VP2 gene of very virulent infectious bursal disease virus (vvIBDV) delivered by transgenic E. coli DH5alpha given orally confers protective immune responses in chickens.
    Mahmood MS; Hussain I; Siddique M; Akhtar M; Ali S
    Vaccine; 2007 Nov; 25(44):7629-35. PubMed ID: 17913306
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza.
    Veits J; Wiesner D; Fuchs W; Hoffmann B; Granzow H; Starick E; Mundt E; Schirrmeier H; Mebatsion T; Mettenleiter TC; Römer-Oberdörfer A
    Proc Natl Acad Sci U S A; 2006 May; 103(21):8197-202. PubMed ID: 16717197
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of co-administration of DNA carrying chicken interferon-gamma gene on protection of chickens against infectious bursal disease by DNA-mediated vaccination.
    Hsieh MK; Wu CC; Lin TL
    Vaccine; 2006 Nov; 24(47-48):6955-65. PubMed ID: 17050043
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [A recombinant fowlpox virus expressing the fusion protein of Newcastle disease virus strain F48E8 and its protective efficacy].
    Wu YT; Peng DX; Liu XF; Liu WZ; Zhang RK
    Sheng Wu Gong Cheng Xue Bao; 2000 Sep; 16(5):591-4. PubMed ID: 11191764
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Impact of modification of cleavage site of fusion protein and foreign gene insertion on the virulence of Newcastle Disease Virus LaSota vaccine strain].
    Wang Y; Ge J; Xie X; Ding Y; Bu Z
    Wei Sheng Wu Xue Bao; 2008 Mar; 48(3):362-8. PubMed ID: 18479064
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Generation and evaluation of a recombinant Newcastle disease virus strain R2B with an altered fusion protein cleavage site as a vaccine candidate.
    Yadav K; Pathak DC; Saikia DP; Debnath A; Ramakrishnan S; Dey S; Chellappa MM
    Microb Pathog; 2018 May; 118():230-237. PubMed ID: 29578068
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of a natural multi-recombinant of Newcastle disease virus.
    Han GZ; He CQ; Ding NZ; Ma LY
    Virology; 2008 Feb; 371(1):54-60. PubMed ID: 18028976
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic fusion of three tandem copies of murine C3d sequences to diphtheria toxin fragment B elicits a decreased fragment B-specific antibody response.
    Gor DO; Ding X; Li Q; Greenspan NS
    Immunol Lett; 2006 Jan; 102(1):38-49. PubMed ID: 16105692
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Cloning and sequence analysis of the molecular-adjuvant gene of the complement C3d of mouse].
    Sun M; Zhao L; Chen S; Wang S; Zhou T; Tang H; Chen Y; Yan J
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Apr; 34(2):257-9. PubMed ID: 12947705
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genomic sequences of low-virulence avian paramyxovirus-1 (Newcastle disease virus) isolates obtained from live-bird markets in North America not related to commonly utilized commercial vaccine strains.
    Seal BS; Wise MG; Pedersen JC; Senne DA; Alvarez R; Scott MS; King DJ; Yu Q; Kapczynski DR
    Vet Microbiol; 2005 Mar; 106(1-2):7-16. PubMed ID: 15737469
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Complement 3d: from molecular adjuvant to target of immune escape mechanisms.
    Bergmann-Leitner ES; Leitner WW; Tsokos GC
    Clin Immunol; 2006 Nov; 121(2):177-85. PubMed ID: 16914381
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Effect of modified NDV F48E9 strain HN gene and in vitro expression of its DNA vaccine].
    He S; Shi X; Wang Y; Wang M; Ran D; Tong G
    Sheng Wu Gong Cheng Xue Bao; 2008 Feb; 24(2):226-31. PubMed ID: 18464605
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Emergence of a new genetic lineage of Newcastle disease virus in West and Central Africa--implications for diagnosis and control.
    Cattoli G; Fusaro A; Monne I; Molia S; Le Menach A; Maregeya B; Nchare A; Bangana I; Maina AG; Koffi JN; Thiam H; Bezeid OE; Salviato A; Nisi R; Terregino C; Capua I
    Vet Microbiol; 2010 May; 142(3-4):168-76. PubMed ID: 19939590
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fusion of C3d molecule with neutralization epitope(s) of hepatitis E virus enhances antibody avidity maturation and neutralizing activity following DNA immunization.
    Yang S; Wang C; Fang X; Zhai L; Dong C; Ding L; Meng J; Wang L
    Virus Res; 2010 Aug; 151(2):162-9. PubMed ID: 20451569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.